cancers-logo

Journal Browser

Journal Browser

Genetic Alterations and Features in the Development of Gastrointestinal Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 83

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Chemical Biology (ICB), National Hellenic Research Foundation (NHRF), 48 Vasileos Constantinou Avenue, 11635 Athens, Greece
Interests: genetics; tumor heterogeneity; cancer biology

Special Issue Information

Dear Colleagues,

Gastrointestinal (GI) cancers develop through the multifaceted interplay of genetic alterations, epigenetic changes, and environmental influences. Beyond somatic mutations and chromosomal instability, factors such as diet, nutrition, chronic infections (e.g., Helicobacter pylori, hepatitis viruses), and gut microbiome dysbiosis significantly contribute to tumorigenesis and progression. These elements can modulate inflammation, immune response, and even mutational landscapes. This Special Issue welcomes original research and reviews exploring the molecular, microbial, infectious, and lifestyle-related determinants of GI cancers. By integrating basic, translational, and clinical perspectives, we aim to advance precision prevention, diagnostics, and therapy in this diverse and impactful disease group.

Dr. Alexandra Voutsina
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gastrointestinal cancers
  • genetic alteration
  • epigenetic regulation
  • the mechanism of tumorigenesis
  • precision treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

44 pages, 2486 KB  
Review
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers
by Maurizio Capuozzo, Carmine Picone, Francesco Sabbatino, Mariachiara Santorsola, Francesco Caraglia, Domenico Iervolino, Roberto Sirica, Oreste Gualillo, Giordana Di Mauro, Rosa Castiello, Monica Ianniello, Alessia Maria Cossu, Angela Nebbioso, Lucia Altucci, Francesco Izzo, Renato Patrone, Andrea Belli, Massimiliano Berretta, Marco Cascella, Francesco Perri, Anna Chiara Carratù, Guglielmo Nasti, Massimo Di Maio, Antonio Giordano, Giovanni Savarese, Michele Caraglia and Alessandro Ottaianoadd Show full author list remove Hide full author list
Cancers 2025, 17(21), 3438; https://doi.org/10.3390/cancers17213438 (registering DOI) - 27 Oct 2025
Abstract
Colorectal cancer (CRC) is among the most prevalent malignancies worldwide, representing the second leading cause of cancer-related mortality and accounting for approximately 2 million new cases and nearly half a million deaths annually. Global age-standardized incidence rates are highest in Australia/New Zealand and [...] Read more.
Colorectal cancer (CRC) is among the most prevalent malignancies worldwide, representing the second leading cause of cancer-related mortality and accounting for approximately 2 million new cases and nearly half a million deaths annually. Global age-standardized incidence rates are highest in Australia/New Zealand and other Western countries, and lowest in parts of sub-Saharan Africa and South Asia, reflecting variations in demographics, lifestyle exposures, and screening practices. Colon cancer constitutes the larger fraction of CRC cases, with rectal cancer contributing substantially, and early-onset CRC (<50 years) is increasing across both high-income and emerging regions. Established risk factors include age, hereditary syndromes, obesity, sedentary behavior, dietary patterns, metabolic disorders, and chronic inflammation, with notable distinctions between colon and rectal subsites. This narrative review provides a comprehensive overview of CRC epidemiology, molecular and genetic pathogenesis, staging, and modern therapeutic approaches, addressing colon and rectal cancers separately due to their distinct biology, clinical behavior, and treatment strategies. By integrating current knowledge on genetic drivers, systemic and local therapies, and patient stratification, the review aims to inform clinical practice, support clinical trial design, discuss ongoing challenges and future perspectives, and foster further research toward precision-guided management of CRC. Full article
Show Figures

Figure 1

Back to TopTop